Cancer treatment with artificial intelligence: how can Europe compete in light of the globally challenging situation?

Sunday, Mar 23, 2025

HVG

Precision oncology advances using AI and personalized treatments, contrasting with rising cancer statistics globally.

🔗 Read the article on hvg.hu

[This is an automatically generated summary, for reference only]

A therapeutic method developed by István Peták, founder of Genomate Health, focuses on correcting genetic errors in cancer cells rather than treating general cancer types, aiming for significant success in various cancers. This precision oncology approach examines the genetic background of tumors to develop and select targeted drugs based on the cancer’s biological function and molecular targets. Unlike traditional methods like chemotherapy or radiation that affect all rapidly dividing cells, this method specifically targets faulty genes within cancerous cells while sparing healthy ones. Peták’s research company utilizes artificial intelligence to enhance cancer diagnosis, oncology treatment, and drug development, earning a European “Future Unicorn” award in 2021. The methodology employs a knowledge network of 80,000 decisions and specialized algorithms to assist doctors in choosing the most suitable personalized therapy. Globally, cancer is a major health threat; in Hungary, the number of newly registered cases has been increasing, which Peták attributes partly to lifestyle factors like high rates of smoking and obesity, alongside poor preventative measures such as low participation in colon or breast cancer screenings. Internationally, while Europe accounts for only 10% of the global population, it bears 20% of all cancer-related deaths, with projections indicating a rise to 3.24 million victims by 2040 if trends continue. European Union initiatives support oncology startups, though they face competition from US and Chinese companies. Innovations include AI systems for bone metastasis diagnosis (e.g., Spotlab in Spain) and personalized tumor vaccines being developed by Swiss company Vaccentis. Furthermore, pediatric cancer treatment shows high success rates through immune-boosting cell therapies at institutions like the Santaros Clinic in Lithuania.

🔗 Read the original article

Previous page Would you be willing to accept a lower quality of life in exchange for greater security? All the sacrifices we, as Europeans, will have to make
Next page "Yes, you are a miracle!" The miraculous survival of a baby girl weighing just 500 grams highlights how fragile life can be

© 2026 Pulse - Europe beyond the beat


PULSE is an initiative for cross-border collaborative journalism in Europe co-funded by the European Commission under Grant Agreement n. PO 4500158093.

PULSE is an initiative coordinated by OBCT that has been promoting intensive journalistic cross-border collaborations in Europe since 2024. Its main aim is to help strengthen the European public sphere by reporting on and telling stories from new and diverse perspectives.

At the heart of PULSE are 10 leading national news outlets (Delfi – Lithuania, Deník Referendum – Czechia, Der Standard – Austria, EfSyn – Greece, El Confidencial – Spain, Gazeta Wyborcza – Poland, HotNews – Romania, HVG – Hungary, Il Sole 24 Ore – Italy, Mediapool – Bulgaria) and three transnational organisations, including OBCT , n-ost and Voxeurop .

Additional outlets and journalists are involved as associate partners, including EUobserver , Føljeton (Denmark), H-Alter (Croatia), Levila (Estonia), Rubryka (Ukraine), and The Journal Investigates (Ireland).

PULSE is driven by a sort of virtual transnational newsroom made up of journalists from all the publications involved. It collaboratively produces new journalistic content on European issues on a daily basis, coming in many different languages. The editorial output amounts to over a thousand publications per year, mostly in article form.

PULSE also runs 4 thematic networks open to any European journalist interested in crucial issues such as EU enlargement, relations between the EU and other global powers, the EU’s green transition, or media and the information society. These networks function as online communities and periodically publish calls for pitches.